Repository logo
 
Publication

Clinical and Molecular Methods in Drug Development: Neoadjuvant Systemic Therapy in Breast Cancer as a Model.

dc.contributor.authorBraga, Sofia
dc.date.accessioned2017-04-07T15:57:28Z
dc.date.available2017-04-07T15:57:28Z
dc.date.issued2016
dc.description.abstractNeoadjuvant chemotherapy (NACT), neoadjuvant endocrine therapy (NAET), and neoadjuvant targeted therapy (NATT), more recently, have been adopted worldwide as standard of care in locally advanced and inoperable BC. These modalities, collectively called neoadjuvant systemic therapy (NAST), are also used for organ preservation and for mechanistic biological studies on drug response and resistance, drug development, and clinical trials. Furthermore, the response to NACT is a valuable indicator of long-term survival. In this work, the advantages and pitfalls of using NAST in BC for studying drug response and resistance for drug development and clinical trials are discussed as well as practical points on how to set up a NAST clinical trial in BC.
dc.identifier.doi10.1007/978-1-4939-3347-1_15
dc.identifier.urihttp://hdl.handle.net/10400.1/9718
dc.language.isoeng
dc.peerreviewedyes
dc.relation.isbasedonMEDLINE:26910079
dc.titleClinical and Molecular Methods in Drug Development: Neoadjuvant Systemic Therapy in Breast Cancer as a Model.
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage280
oaire.citation.startPage251
oaire.citation.titleMethods in molecular biology (Clifton, N.J.)
oaire.citation.volume1395
person.familyNameAzambuja Duarte Santos Braga
person.givenNameSofia
person.identifier.ciencia-id3F1C-792B-93F2
rcaap.rightsopenAccess
rcaap.typearticle
relation.isAuthorOfPublication12a87242-e3c0-4165-b9de-8c318b8e2e14
relation.isAuthorOfPublication.latestForDiscovery12a87242-e3c0-4165-b9de-8c318b8e2e14

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
braga2016.pdf
Size:
647.16 KB
Format:
Adobe Portable Document Format